Active Biotech's election committee appointed
19 11월 2018 - 4:30PM
PRESS RELEASE
In accordance
with a decision made by the Annual General Meeting held on May 17,
2018, the Election Committee shall comprise the representatives for
the three largest shareholders by votes, as per end of September
2018, and the Chairman of the Board.
For the 2019 Annual General
Meeting, the Election Committee shall propose Board members and a
Chairman of the Board, and fees to Board members and auditors. The
following individuals were appointed representatives for the
largest shareholders by votes and, accordingly, are members of the
Election Committee:
Johnny Sommarlund, MGA
Holding
Tomas Billing, Nordstjernan
Reza Khiabani, representing own holdings
Under the leadership of the
Chairman of the Board, Mats Arnhög, the Election Committee shall
prepare proposals to be presented to and decided upon at the Annual
General Meeting on May 23, 2019.
Lund, November 19, 2018
Active Biotech AB (publ)
Helén Tuvesson
President and CEO
For further information, please
contact:
Hans Kolam, CFO
Tel: +46 (0)46 19 20 44
Active Biotech AB (publ)
(NASDAQ Stockholm: ACTI) is a biotechnology company with focus on
neurodegenerative/inflammatory diseases and cancer. Laquinimod, an
orally administered small molecule with unique immunomodulatory
properties in development for neurodegenerative diseases. ANYARA,
an immunotherapy, in development for cancer indications in
partnership with NeoTX Therapeutics Ltd. Furthermore, commercial
activities are conducted for the tasquinimod, paquinimod and SILC
projects. Please visit www.activebiotech.com for more
information.
Active Biotech AB
(Corp. Reg. No. 556223-9227)
Box 724, SE-220 07 Lund, Sweden
Tel: +46 (0)46 19 20 00
This information was submitted for publication,
through the agency of the contact person set out above,
at 08.30 a.m. CET on November
19, 2018.
Active Biotech's election committee
appointed
This
announcement is distributed by West Corporation on behalf of West
Corporation clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Active Biotech via Globenewswire
Actividentity Corp (MM) (NASDAQ:ACTI)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Actividentity Corp (MM) (NASDAQ:ACTI)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024